Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
Marta MellaiLaura AnnovazziIlaria BisognoCristiano CoronaPaola CrociaraBarbara IuliniPaola CassoniCristina CasaloneRenzo BoldoriniDavide SchifferPublished in: Cells (2020)
The immunoreactivity of NG2/CSPG4 provides information on the timing of the neoplastic transformation and could have prognostic and therapeutic relevance as a promising tumor-associated antigen for antibody-based immunotherapy in patients with malignant gliomas.